Komori
CellSource (4880) · RiskRestated

Dependence on an Outsourced Cosmetics Manufacturing Provider

First written in FY2019. 3 of 4 entries say "Restated". Latest entry: FY2022.

4entries
4years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2019 – FY20222020: 120202021: 120212022: 120222023: 1
Same theme, other companies
Risk of insufficient supply capacity and shutdowns at outsourced production partnersA theme 66 companies write about · 68 as a headwind · 0 as a tailwind

The whole theme swung hardest in 2024: 10 of 32 companies on the "Worse" side.

34 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 66 companies compared. The sentences above are computed from all 66.
Full recordFilings, disclosures and news, newest first
  1. FY2022RestatedAnnual report

    「For cosmetics under the “SignaLift” brand, we do not own manufacturing facilities for the products we sell and outsource all manufacturing to 株式会社シャローム.」

    The structure of fully outsourcing cosmetics manufacturing to 株式会社シャローム, and the risks associated with an inability to continue the outsourcing arrangement or a production stoppage, remain.
  2. FY2021RestatedAnnual report

    「For cosmetics under the “SignaLift” brand, we do not own manufacturing facilities for the products we sell and outsource all manufacturing to 株式会社シャローム.」

    The structure of fully outsourcing cosmetics manufacturing to 株式会社シャローム, and the risks associated with an inability to continue the outsourcing arrangement or a production stoppage, remain.
  3. FY2020RestatedAnnual report

    「We do not own manufacturing facilities for the products we sell and outsource all manufacturing to 株式会社シャローム.」

    The structure of relying on a single external contractor for cosmetics manufacturing remains.
  4. FY2019First statedAnnual report

    「We do not own manufacturing facilities for the products we sell and outsource all manufacturing to 株式会社シャローム. Accordingly, if for any reason it becomes impossible to continue outsourcing manufacturing to that company」

    Risks include the inability to continue the contract with the sole contract manufacturer and production stoppages caused by accidents or natural disasters.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for CellSource yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.